Pictor Receives CE Mark for its PictArray SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster
Following a recent funding round raising $6.1 million (NZD $8.8 million), biotech company Pictor today announced it has received confirmation of CE registration for its PictArray SARS-CoV-2 IgG enzyme-linked
Kostenloser Wertpapierhandel Howard Moore Tadd Lazarus Pictor Pictarray World Health Organization Public Health Emergency Of International Concern
Source: finanznachrichten.de